Safe Group Confirms Its International Growth Roadmap
Safe Group, a French medical technology company, announced on Thursday, February 4, its 2025 revenue figures and confirmed its development strategy. The group continues to focus on growth driven by internationalization and increased production capacity.
Revenue Growth in 2025
Safe Group recorded an increase in revenue in 2025. Domestic activity in France is progressing, confirming the strength of the local market. Internationally, there is a significant uptick in dynamics, reflecting a strong increase in activity outside of France. The European economic zone has seen a slight decline. This performance illustrates the group's strategic priority towards international development.
Revenue Structure Evolution in 2025
The year 2025 marks a shift in the group's revenue structure. Safe Group has made efforts to improve its industrial capacity and has revamped its commercial organization. These changes are part of the strategic vision initiated two years ago, which focuses on international development and strengthening production activities. The group continues its transformation to consolidate its growth.
